Literature DB >> 16790084

In vivo direct molecular imaging of early tumorigenesis and malignant progression induced by transgenic expression of GFP-Met.

Sharon Moshitch-Moshkovitz1, Galia Tsarfaty, Dafna W Kaufman, Gideon Y Stein, Keren Shichrur, Eddy Solomon, Robert H Sigler, James H Resau, George F Vande Woude, Ilan Tsarfaty.   

Abstract

The tyrosine kinase receptor Met and its ligand, hepatocyte growth factor/scatter factor (HGF/SF), play an important role in normal developmental processes, as well as in tumorigenicity and metastasis. We constructed a green fluorescent protein (GFP) Met chimeric molecule that functions similarly to the wild-type Met receptor and generated GFP-Met transgenic mice. These mice ubiquitously expressed GFP-Met in specific epithelial and endothelial cells and displayed enhanced GFP-Met fluorescence in sebaceous glands. Thirty-two percent of males spontaneously developed adenomas, adenocarcinomas, and angiosarcomas in their lower abdominal sebaceous glands. Approximately 70% of adenocarcinoma tumors metastasized to the kidneys, lungs, or liver. Quantitative subcellular-resolution intravital imaging revealed very high levels of GFP-Met in tumor lesions and in single isolated cells surrounding them, relative to normal sebaceous glands. These single cells preceded the formation of local and distal metastases. Higher GFP-Met levels correlated with earlier tumor onset and aggressiveness, further demonstrating the role of Met-HGF/SF signaling in cellular transformation and acquisition of invasive and metastatic phenotypes. Our novel mouse model and high-resolution intravital molecular imaging create a powerful tool that enables direct real-time molecular imaging of receptor expression and localization during primary events of tumorigenicity and metastasis at single-cell resolution.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16790084      PMCID: PMC1592452          DOI: 10.1593/neo.05634

Source DB:  PubMed          Journal:  Neoplasia        ISSN: 1476-5586            Impact factor:   5.715


  56 in total

Review 1.  Scatter-factor and semaphorin receptors: cell signalling for invasive growth.

Authors:  Livio Trusolino; Paolo M Comoglio
Journal:  Nat Rev Cancer       Date:  2002-04       Impact factor: 60.716

2.  Vascular networks and endothelial cells in the rat experimental pituitary glands and in the human pituitary adenomas.

Authors:  Johbu Itoh; Akihiko Serizawa; Kenji Kawai; Yudo Ishii; Akira Teramoto; Robert Yoshiyuki Osamura
Journal:  Microsc Res Tech       Date:  2003-02-01       Impact factor: 2.769

3.  Met protein expression level correlates with survival in patients with late-stage nasopharyngeal carcinoma.

Authors:  Chao-Nan Qian; Xiang Guo; Brian Cao; Eric J Kort; Chong-Chou Lee; Jindong Chen; Ling-Mei Wang; Wei-Yuan Mai; Hua-Qing Min; Ming-Huang Hong; George F Vande Woude; James H Resau; Bin Tean Teh
Journal:  Cancer Res       Date:  2002-01-15       Impact factor: 12.701

4.  Met-HGF/SF signal transduction induces mimp, a novel mitochondrial carrier homologue, which leads to mitochondrial depolarization.

Authors:  Gil M Yerushalmi; Raya Leibowitz-Amit; Miriam Shaharabany; Ilan Tsarfaty
Journal:  Neoplasia       Date:  2002 Nov-Dec       Impact factor: 5.715

5.  GFP-transfected tumor cells are useful in examining early metastasis in vivo, but immune reaction precludes long-term tumor development studies in immunocompetent mice.

Authors:  Markus Steinbauer; Markus Guba; Grigore Cernaianu; Gudrun Köhl; Michaela Cetto; Leoni A Kunz-Schughart; Edward K Geissler; Werner Falk; Karl-Walter Jauch
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

6.  Immunohistochemically detected hepatic micrometastases predict a high risk of intrahepatic recurrence after resection of colorectal carcinoma liver metastases.

Authors:  Naoyuki Yokoyama; Yoshio Shirai; Yoich Ajioka; Shigenori Nagakura; Takeyasu Suda; Katsuyoshi Hatakeyama
Journal:  Cancer       Date:  2002-03-15       Impact factor: 6.860

7.  Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer.

Authors:  Jung Y Kang; Marisa Dolled-Filhart; Idris Tolgay Ocal; Baljit Singh; Chen-Yong Lin; Robert B Dickson; David L Rimm; Robert L Camp
Journal:  Cancer Res       Date:  2003-03-01       Impact factor: 12.701

8.  GFP expression in the mammary gland for imaging of mammary tumor cells in transgenic mice.

Authors:  Fayyaz Ahmed; Jeffrey Wyckoff; Elaine Y Lin; Weigang Wang; Yarong Wang; Lothar Hennighausen; Jun-ichi Miyazaki; Joan Jones; Jeffrey W Pollard; John S Condeelis; Jeffrey E Segall
Journal:  Cancer Res       Date:  2002-12-15       Impact factor: 12.701

Review 9.  The organ microenvironment and cancer metastasis.

Authors:  Isaiah J Fidler
Journal:  Differentiation       Date:  2002-12       Impact factor: 3.880

Review 10.  Being in the right location at the right time.

Authors:  R Pepperkok; J C Simpson; S Wiemann
Journal:  Genome Biol       Date:  2001-08-29       Impact factor: 13.583

View more
  13 in total

Review 1.  Targeting MET in cancer: rationale and progress.

Authors:  Ermanno Gherardi; Walter Birchmeier; Carmen Birchmeier; George Vande Woude
Journal:  Nat Rev Cancer       Date:  2012-01-24       Impact factor: 60.716

Review 2.  Real-time intravital imaging of cancer models.

Authors:  A Zomer; E Beerling; E J Vlug; J van Rheenen
Journal:  Clin Transl Oncol       Date:  2011-12       Impact factor: 3.405

Review 3.  Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges.

Authors:  Conor A Bradley; Manuel Salto-Tellez; Pierre Laurent-Puig; Alberto Bardelli; Christian Rolfo; Josep Tabernero; Hajrah A Khawaja; Mark Lawler; Patrick G Johnston; Sandra Van Schaeybroeck
Journal:  Nat Rev Clin Oncol       Date:  2017-04-04       Impact factor: 66.675

4.  Neoplasia: the second decade.

Authors:  Alnawaz Rehemtulla
Journal:  Neoplasia       Date:  2008-12       Impact factor: 5.715

5.  MACC1, a newly identified key regulator of HGF-MET signaling, predicts colon cancer metastasis.

Authors:  Ulrike Stein; Wolfgang Walther; Franziska Arlt; Holger Schwabe; Janice Smith; Iduna Fichtner; Walter Birchmeier; Peter M Schlag
Journal:  Nat Med       Date:  2008-12-21       Impact factor: 53.440

Review 6.  Tumor cell migration in complex microenvironments.

Authors:  William J Polacheck; Ioannis K Zervantonakis; Roger D Kamm
Journal:  Cell Mol Life Sci       Date:  2012-08-25       Impact factor: 9.261

Review 7.  MET: a critical player in tumorigenesis and therapeutic target.

Authors:  Carrie R Graveel; David Tolbert; George F Vande Woude
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

8.  Mutations Preventing Regulated Exon Skipping in MET Cause Osteofibrous Dysplasia.

Authors:  Mary J Gray; Peter Kannu; Swarkar Sharma; Christine Neyt; Dongping Zhang; Nandina Paria; Philip B Daniel; Heather Whetstone; Hans-Georg Sprenger; Philipp Hammerschmidt; Angela Weng; Lucie Dupuis; Rebekah Jobling; Roberto Mendoza-Londono; Michael Dray; Peiqiang Su; Megan J Wilson; Raj P Kapur; Edward F McCarthy; Benjamin A Alman; Andrew Howard; Gino R Somers; Christian R Marshall; Simon Manners; Adrienne M Flanagan; Karl E Rathjen; Lori A Karol; Haemish Crawford; David M Markie; Jonathan J Rios; Carol A Wise; Stephen P Robertson
Journal:  Am J Hum Genet       Date:  2015-12-03       Impact factor: 11.025

9.  MARCH Proteins Mediate Responses to Antitumor Antibodies.

Authors:  Jailal N Ablack; Jesus Ortiz; Jeevisha Bajaj; Kathleen Trinh; Frederic Lagarrigue; Joseph M Cantor; Tannishtha Reya; Mark H Ginsberg
Journal:  J Immunol       Date:  2020-10-19       Impact factor: 5.426

10.  Single-molecule photobleaching reveals increased MET receptor dimerization upon ligand binding in intact cells.

Authors:  Marina S Dietz; Daniel Haße; Davide M Ferraris; Antonia Göhler; Hartmut H Niemann; Mike Heilemann
Journal:  BMC Biophys       Date:  2013-06-03       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.